Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1997;75(8):1217–1218. doi: 10.1038/bjc.1997.208

Rising serum values of beta-subunit human chorionic gonadotrophin (hCG) in patients with progressive vulvar carcinomas.

H W de Bruijn 1, K A ten Hoor 1, M Krans 1, A G van der Zee 1
PMCID: PMC2222794  PMID: 9099973

Abstract

Elevated serum levels of the beta-subunit of human chorionic gonadotrophin (hCG) were measured in 50% of patients with locoregional recurrences or progressive vulvar carcinoma (n = 14). At diagnosis of vulvar cancer, however, the incidence of elevated serum levels was low (5%) in 104 patients. The rising serum levels during progression of disease indicate that the synthesis of the beta-subunit hCG can be increased in vulvar carcinoma.

Full text

PDF
1218

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acevedo H. F., Tong J. Y., Hartsock R. J. Human chorionic gonadotropin-beta subunit gene expression in cultured human fetal and cancer cells of different types and origins. Cancer. 1995 Oct 15;76(8):1467–1475. doi: 10.1002/1097-0142(19951015)76:8<1467::aid-cncr2820760826>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  2. Burger M. P., Hollema H., Emanuels A. G., Krans M., Pras E., Bouma J. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol. 1995 Jun;57(3):327–334. doi: 10.1006/gyno.1995.1151. [DOI] [PubMed] [Google Scholar]
  3. Carter P. G., Iles R. K., Neven P., Ind T. E., Shepherd J. H., Chard T. Measurement of urinary beta core fragment of human chorionic gonadotrophin in women with vulvovaginal malignancy and its prognostic significance. Br J Cancer. 1995 Feb;71(2):350–353. doi: 10.1038/bjc.1995.70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kinugasa M., Nishimura R., Koizumi T., Morisue K., Higashida T., Natazuka T., Nakagawa T., Isobe T., Baba S., Hasegawa K. Combination assay of urinary beta-core fragment of human chorionic gonadotropin with serum tumor markers in gynecologic cancers. Jpn J Cancer Res. 1995 Aug;86(8):783–789. doi: 10.1111/j.1349-7006.1995.tb02469.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lazo de la Vega S., Volkow P., Yeates R. A., Pfaff G. Administration of the antimycotic agents fluconazole and itraconazole to leukaemia patients: a comparative pharmacokinetic study. Drugs Exp Clin Res. 1994;20(2):69–75. [PubMed] [Google Scholar]
  6. Patsner B., Mann W. J. Serum squamous cell carcinoma antigen levels in patients with invasive squamous vulvar and vaginal cancer: a preliminary report. Gynecol Oncol. 1989 Jun;33(3):323–325. doi: 10.1016/0090-8258(89)90520-9. [DOI] [PubMed] [Google Scholar]
  7. Rose P. G., Nelson B. E., Fournier L., Hunter R. E. Serum squamous cell carcinoma antigen levels in invasive squamous vulvar cancer. J Surg Oncol. 1992 Jul;50(3):183–186. doi: 10.1002/jso.2930500311. [DOI] [PubMed] [Google Scholar]
  8. van der Sijde R., de Bruijn H. W., Krans M., Bouma J., Aalders J. G. Significance of serum SCC antigen as a tumor marker in patients with squamous cell carcinoma of the vulva. Gynecol Oncol. 1989 Nov;35(2):227–232. doi: 10.1016/0090-8258(89)90049-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES